Norman T R, Walker R G, Burrows G D
Clin Pharmacokinet. 1984 Jul-Aug;9(4):349-53. doi: 10.2165/00003088-198409040-00004.
The renal clearance of lithium will decrease, and hence the risk of acute lithium toxicity will increase, in any situation leading to dehydration and sodium depletion. Patients on long term lithium therapy with progressively declining urinary concentrating ability may be at special risk in this regard. Chronic histological changes in the kidney attributed to lithium therapy correlate with age rather than with the duration of lithium therapy. Age-related renal histological changes are associated with decreased glomerular filtration rate and therefore reduced renal lithium clearance. Thus, the dose of lithium should be reduced with advancing age.
在任何导致脱水和钠缺乏的情况下,锂的肾脏清除率都会降低,因此急性锂中毒的风险会增加。长期接受锂治疗且尿浓缩能力逐渐下降的患者在这方面可能面临特殊风险。归因于锂治疗的肾脏慢性组织学变化与年龄相关,而非与锂治疗的持续时间相关。与年龄相关的肾脏组织学变化与肾小球滤过率降低有关,因此肾脏对锂的清除率也会降低。因此,随着年龄的增长,锂的剂量应减少。